Tuberculosis, the world's top infectious disease, never really received priority in funding or R&D over the years and “covidization” of all major aspects in the healthcare sector has now diverted the focus further away from TB, amplifying challenges and threatening to undo years of progress in the segment.
Dr Madhukar Pai, Canada Research Chair in Translational Epidemiology and Global Health and Director at the McGill International TB Centre, outlined the distressing situation on the ground in which people with TB are very hesitant to seek care, and even if they do, facilities are closed or they are